Castle Biosciences Inc (CSTL)
27.72
+0.24
(+0.87%)
USD |
NASDAQ |
Dec 24, 16:00
Castle Biosciences Cash from Investing (Quarterly): -14.79M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Delcath Systems Inc | -0.697M |
| Star Equity Holdings Inc | 6.451M |
| Exact Sciences Corp | -81.72M |
| CytoSorbents Corp | -0.2984M |
| Progyny Inc | 15.36M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 23.34M |
| Cash from Financing (Quarterly) | 0.838M |
| Free Cash Flow | 34.54M |
| Free Cash Flow Per Share (Quarterly) | 0.5769 |
| Free Cash Flow to Equity (Quarterly) | 16.95M |
| Free Cash Flow to Firm (Quarterly) | 16.96M |
| Free Cash Flow Yield | 4.42% |